Canadian Pharmacy Blog

Cetuximab (Erbitux) is now approved for use in combination with radiation therapy to treat patients with un-resectable squamous cell cancer of the head and neck. It is manufactured by ImClone Systems and will be distributed and marketed by Bristol-Myers Squibb. prevacid drug
This is the first drug approved for head and neck cancer that has shown survival [...]

The Food and Drug Administration (FDA) has approved temsirolimus (Torisel, Wyeth) for the treatment of advanced kidney cancer.
In a clinical trial of 626 patients, one group received the study drug alone, another received a comparator agent (interferon alfa), and the third group received a combination of the two. The temsirolimus-alone group showed a significant improvement [...]